Maxcyte (MXCT) Non-Current Assets (2020 - 2026)

Maxcyte (MXCT) has 7 years of Non-Current Assets data on file, last reported at $71.5 million in Q1 2026.

• On a quarterly basis, Non-Current Assets fell 3.61% year-over-year to $71.5 million in Q1 2026; TTM through Mar 2026 was $321.0 million, a 9.36% increase from a year earlier, with the FY2025 full-year figure at $84.1 million, up 24.12% from the prior year.
• Non-Current Assets for Q1 2026 stood at $71.5 million, down from $84.1 million in the prior quarter.
• Over the last five years, Non-Current Assets for MXCT reached as high as $88.8 million in Q3 2025 and fell as low as $25.2 million in Q1 2022.
• Historically, Non-Current Assets has averaged $60.0 million across 5 years, with a median of $71.5 million in 2026.
• Across the five-year window, Non-Current Assets jumped 318.61% in 2022 and slipped 13.18% in 2024, its largest moves.
• Year by year, Non-Current Assets stood at $34.4 million in 2022, then surged by 127.06% to $78.1 million in 2023, then dropped by 13.18% to $67.8 million in 2024, then gained by 24.12% to $84.1 million in 2025, then declined by 14.98% to $71.5 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $71.5 million in Q1 2026, $84.1 million in Q4 2025, and $88.8 million in Q3 2025.